Autoimmunity in the Pathogenesis of AF

NCT03498729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2022-02-21

No results posted yet for this study

Summary

This research study is being done to find out whether autoimmune mechanisms are associated with the development of atrial fibrillation.

Conditions

Interventions

OTHER

Peripheral Blood Sample

30mL peripheral whole blood sample

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Rowlens M. Melduni, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-05
Primary Completion
2021-12-09
Completion
2021-12-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03498729 on ClinicalTrials.gov